Preeclampsia as a Risk Factor for Diabetes: A Population-Based Cohort Study

English version České info

Background:
Women with preeclampsia (PEC) and gestational hypertension (GH) exhibit insulin resistance during pregnancy, independent of obesity and glucose intolerance. Our aim was to determine whether women with PEC or GH during pregnancy have an increased risk of developing diabetes after pregnancy, and whether the presence of PEC/GH in addition to gestational diabetes (GDM) increases the risk of future (postpartum) diabetes.

Methods and Findings:
We performed a population-based, retrospective cohort study for 1,010,068 pregnant women who delivered in Ontario, Canada between April 1994 and March 2008. Women were categorized as having PEC alone (n = 22,933), GH alone (n = 27,605), GDM alone (n = 30,852), GDM+PEC (n = 1,476), GDM+GH (n = 2,100), or none of these conditions (n = 925,102). Our main outcome was a new diagnosis of diabetes postpartum in the following years, up until March 2011, based on new records in the Ontario Diabetes Database. The incidence rate of diabetes per 1,000 person-years was 6.47 for women with PEC and 5.26 for GH compared with 2.81 in women with neither of these conditions. In the multivariable analysis, both PEC alone (hazard ratio [HR] = 2.08; 95% CI 1.97–2.19) and GH alone (HR = 1.95; 95% CI 1.83–2.07) were risk factors for subsequent diabetes. Women with GDM alone were at elevated risk of developing diabetes postpartum (HR = 12.77; 95% CI 12.44–13.10); however, the co–presence of PEC or GH in addition to GDM further elevated this risk (HR = 15.75; 95% CI 14.52–17.07, and HR = 18.49; 95% CI 17.12–19.96, respectively). Data on obesity were not available.

Conclusions:
Women with PEC/GH have a 2-fold increased risk of developing diabetes when followed up to 16.5 years after pregnancy, even in the absence of GDM. The presence of PEC/GH in the setting of GDM also raised the risk of diabetes significantly beyond that seen with GDM alone. A history of PEC/GH during pregnancy should alert clinicians to the need for preventative counseling and more vigilant screening for diabetes.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Preeclampsia as a Risk Factor for Diabetes: A Population-Based Cohort Study. PLoS Med 10(4): e32767. doi:10.1371/journal.pmed.1001425
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001425

Souhrn

Zdroje

1. ZimmetPZ, AlbertiKGMM (2006) Introduction: globalization and the non–communicable disease epidemic. Obesity 14: 1–3.

2. LipscombeLL, HuxJE (2007) Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study. Lancet 369: 750–756.

3. Diabetes Prevention Program Research Group (2002) N Eng J Med 346: 393–403.

4. TuomilehtoJ, LindströmJ, ErikssonJG, ValleTT, HämäläinenH, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Eng J Med 344: 1343–1350.

5. FeigDS, ZinmanB, WangX, HuxJE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179: 229–234.

6. National High Blood Pressure Education Program Working Group (2000) Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183: S1–S22.

7. ParrettiE, lapollaA, DalfraMG, PaciniG, MariA, et al. (2006) Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 47: 449–453.

8. Sierra–LaguadoJ, GarciaRG, CeledónJ, Arenas-MantillaM, PradillaLP, et al. (2007) Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy–induced hypertension. Am J Hypertens 20: 437–442.

9. BrysonCL, IoannouGN, RulyakSJ, CritchlowC (2003) Association between gestational diabetes and gestational hypertension. Am J Epidemiol 158: 1148–1153.

10. VambergueA, NuttensMC, GoeusseP, BiausqueS, LepeutM, et al. (2002) Pregnancy induced hypertension in women with gestational carbohydrate intolerance: the diagest study. European J Obs Gyne Repro Bio 102: 31–35.

11. LegroRS (2009) Insulin resistance in women's health: why it matters and how to identify it. Curr Opin Obstet Gynecol 21: 301–305.

12. JoffeGM, EsterlitzJR, LevineRJ, ClemensJD, EwellMG, et al. (1998) The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 179: 1032–1037.

13. SermerM, NaylorCD, GareDJ (1995) Impact of increasing carbohydrate intolerance on maternal–fetal outcomes in 3637 women without gestational diabetes. Am J Obstet Gynecol 173: 146–156.

14. HuxJE, IvisF, FlintoftV, BicaA (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25: 512–516.

15. Johns Hopkins University (2011) The Johns Hopkins ACG® Case-Mix System Applications Guide Version 10.0 December 2011. Available: http://www.acg.jhsph.org. Accessed 31 January 2013.

16. TuK, CampbellNR, ChenZ, Cauch–DudekK, McAlisterFA (2007) Accuracy of administrative databases in identifying patients with hypertension. Open Medicine 1: 18–26.

17. SchoenfeldD (1980) Chi-squared goodness-of-fit tests for the proportional hazards regression model. Bometrika 67: 145–153.

18. AustinPC (2010) Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes. J Clin Epi 63: 46–55.

19. RyanEA, ImesS, LiuD, McManusR, FinegoodDT, et al. (1995) Defects in insulin secretion and action in women with a history of gestational diabetes. Diabetes 44: 506–512.

20. D'AnnaR, BavieraG, CorradoF, GiordanoD, De VivoA, et al. (2006) Adiponectin and insulin resistance in early– and late–onset preeclampsia. BJOG 113: 1264–1269.

21. FuhMMT, YinCS, PeiD, SheuWH, JengCY, et al. (1995) Resistance to insulin–mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens 8: 768–771.

22. SoonthornpunK, SoonthornpunS, WannaroP, SetasubanW, ThamprasitA (2009) Insulin resistance in women with a history of severe pre–eclampsia. J Obstet Gynaecol Res 35: 55–59.

23. RayJG (2004) Dysmetabolic syndrome, placenta-mediated disease and future risk of cardiovascular disease. Fetal and Mat Med Rev 15: 231–246.

24. SattarN, RamsayJ, CrawfordL, CheyneH, GreerIA (2003) Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 12: 12.

25. GirouardJ, GiguereY, MoutquinJ-M, ForestJ-C (2007) Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 49: 1056–1062.

26. SmithGN, WalkerMC, LiuA, WenSW, SwansburgM, et al. (2009) A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 200: 58.e1–58.e8.

27. AgatisaPK, NessRB, RobertsJM, CostantinoJP, KullerLH, et al. (2004) Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Phsiol Circ Physiol 286: H1389–H1393.

28. KvehaugenAS, DechendR, RamstadHB, TroisiR, FugelsethD, et al. (2011) Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 58: 63–69.

29. HawfieldA, FreedmanBI (2009) Pre–eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis 3: 65–73.

30. CaballeroAE (2004) Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes. Curr Diab Rep 4: 237–246.

31. KjosSL, PetersRK, XiangA, HenryOA, MontoroM, et al. (1995) Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 44: 586–591.

32. CallawayLK, LawlorDA, O'CallaghanM, WilliamsGM, NajmanJM, et al. (2007) Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol 197: 492.e1–492.e7.

33. LykkeJA, Langhoff-RoosJ, SibaiBM, FunaiEF, TricheEW, et al. (2009) Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 53: 944–951.

34. EngelandA, BjorgeT, Kjersti DaltveitAK, SkurtveitS, VangenS, et al. (2011) Risk of diabetes after gestational diabetes and preelampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol 26: 157–163.

35. SinghJ, HuangC-C, DriggersRW, TimofeevJ, AminiD, et al. (2012) The impact of pre-pregnancy body mass index on the risk of gestational diabetes. J Maternal Fetal Neonatal Med 25: 5–10.

36. O'BrienTE, RayJG, ChanW-S (2003) Maternal body mass index and the risk of preeclampsia: a systematic overview. Epi 14: 368–374.

37. TaylorLK, TravisS, PymM, OliveE, Henderson-SmartDJ (2005) How useful are hospital morbidity data for monitoring conditions occurring in the perinatal period? Austr NZ J Obs Gyn 45: 36–41.